Global Women's Health Academy-logo

Global Women's Health Academy

ReachMD

The Global Women's Health Academy (GWHA) Series offers certified education modules and video interviews from leading infertility experts from across the globe as they address topics such as assisted reproductive technologies (ART); the day-to-day working of an IVF laboratory and laboratory quality control; scoring, fertilization, culture, and cryopreservation; time lapse technology; preimplantation genetic screening (PGS) in practice; embryo selection of fresh or frozen embryo transfers; oocyte banking and the wider applications of intra-cytoplasmic sperm injection (ICSI); physiology and anatomy of male infertility; diagnosis of various presentations of infertile males; fertility preservation strategies for individuals with cancer; genetic testing for both males and females; and the emergence of experimental fertility options. For more information about GWHA, visit www.globalwomenshealthacademy.org.

Location:

United States

Networks:

ReachMD

Description:

The Global Women's Health Academy (GWHA) Series offers certified education modules and video interviews from leading infertility experts from across the globe as they address topics such as assisted reproductive technologies (ART); the day-to-day working of an IVF laboratory and laboratory quality control; scoring, fertilization, culture, and cryopreservation; time lapse technology; preimplantation genetic screening (PGS) in practice; embryo selection of fresh or frozen embryo transfers; oocyte banking and the wider applications of intra-cytoplasmic sperm injection (ICSI); physiology and anatomy of male infertility; diagnosis of various presentations of infertile males; fertility preservation strategies for individuals with cancer; genetic testing for both males and females; and the emergence of experimental fertility options. For more information about GWHA, visit www.globalwomenshealthacademy.org.

Language:

English


Episodes

Postpartum Depression: A Significant Burden and a Novel Approach to Treatment

12/5/2023
Host: Lee Shulman MD, FACOG, FACMG Guest: Kristina Deligiannidis, MD The recent development and approval of two neuroactive steroids is likely to change the treatment paradigm for moderate to severe postpartum depression (PPD). These agents have a quick onset and function as GABAA positive allosteric modulators. Join Drs. Shulman and Deligiannidis as they address the burdens and impacts of PPD on mothers, babies, and partners, and deep dive into the pathophysiologic role and clinical findings associated with the use of neuroactive steroids in the management of PPD.

Duration:00:36:28

Integrating Evidence and Cultural Sensitivity in Patient-Centric Insomnia Treatments

9/29/2023
Host: Kevin Trice, MD Host: Michael E. Yurcheshen, MD, FAASM Insomnia is characterized by difficulty falling asleep, staying asleep, and experiencing non-restorative or poor-quality sleep; it often leaves individuals feeling unrefreshed upon awakening. Symptoms during the day may include fatigue, irritability, impaired focus, and excessive sleepiness. The condition can significantly deteriorate a person’s quality of life, leading to reduced productivity, impaired cognitive function, mood disturbances, and an increased risk of accidents or injuries due to daytime sleepiness. This educational program delves into the pathophysiology and diagnosis of insomnia as well as the role of the orexin system in the sleep/wake cycle. The program also evaluates the latest treatments, including the dual orexin receptor antagonists (DORAs), daridorexant, and lemborexant, and how these DORAs compare to other insomnia treatments with the aim of improving treatment choices, reducing adverse events, and improving patient outcomes.

Duration:00:06:00

Examining Treatment Options for Insomnia: From Orexin to GABA

9/29/2023
Host: Kevin Trice, MD Insomnia is characterized by difficulty falling asleep, staying asleep, and experiencing non-restorative or poor-quality sleep; it often leaves individuals feeling unrefreshed upon awakening. Symptoms during the day may include fatigue, irritability, impaired focus, and excessive sleepiness. The condition can significantly deteriorate a person’s quality of life, leading to reduced productivity, impaired cognitive function, mood disturbances, and an increased risk of accidents or injuries due to daytime sleepiness. This educational program delves into the pathophysiology and diagnosis of insomnia as well as the role of the orexin system in the sleep/wake cycle. The program also evaluates the latest treatments, including the dual orexin receptor antagonists (DORAs), daridorexant, and lemborexant, and how these DORAs compare to other insomnia treatments with the aim of improving treatment choices, reducing adverse events, and improving patient outcomes.

Duration:00:05:29

Utilizing Assessment Tools in Insomnia

9/29/2023
Host: Michael E. Yurcheshen, MD, FAASM Insomnia is characterized by difficulty falling asleep, staying asleep, and experiencing non-restorative or poor-quality sleep; it often leaves individuals feeling unrefreshed upon awakening. Symptoms during the day may include fatigue, irritability, impaired focus, and excessive sleepiness. The condition can significantly deteriorate a person’s quality of life, leading to reduced productivity, impaired cognitive function, mood disturbances, and an increased risk of accidents or injuries due to daytime sleepiness. This educational program delves into the pathophysiology and diagnosis of insomnia as well as the role of the orexin system in the sleep/wake cycle. The program also evaluates the latest treatments, including the dual orexin receptor antagonists (DORAs), daridorexant, and lemborexant, and how these DORAs compare to other insomnia treatments with the aim of improving treatment choices, reducing adverse events, and improving patient outcomes.

Duration:00:05:59

Exploring the Impact of Insomnia on Daytime Functioning and Cognition

9/29/2023
Host: Michael E. Yurcheshen, MD, FAASM Host: Kevin Trice, MD Insomnia is characterized by difficulty falling asleep, staying asleep, and experiencing non-restorative or poor-quality sleep; it often leaves individuals feeling unrefreshed upon awakening. Symptoms during the day may include fatigue, irritability, impaired focus, and excessive sleepiness. The condition can significantly deteriorate a person’s quality of life, leading to reduced productivity, impaired cognitive function, mood disturbances, and an increased risk of accidents or injuries due to daytime sleepiness. This educational program delves into the pathophysiology and diagnosis of insomnia as well as the role of the orexin system in the sleep/wake cycle. The program also evaluates the latest treatments, including the dual orexin receptor antagonists (DORAs), daridorexant, and lemborexant, and how these DORAs compare to other insomnia treatments with the aim of improving treatment choices, reducing adverse events, and improving patient outcomes.

Duration:00:05:29

Patient Perspective: Living With Insomnia

9/29/2023
Host: Kevin Trice, MD Insomnia is characterized by difficulty falling asleep, staying asleep, and experiencing non-restorative or poor-quality sleep; it often leaves individuals feeling unrefreshed upon awakening. Symptoms during the day may include fatigue, irritability, impaired focus, and excessive sleepiness. The condition can significantly deteriorate a person’s quality of life, leading to reduced productivity, impaired cognitive function, mood disturbances, and an increased risk of accidents or injuries due to daytime sleepiness. This educational program delves into the pathophysiology and diagnosis of insomnia as well as the role of the orexin system in the sleep/wake cycle. The program also evaluates the latest treatments, including the dual orexin receptor antagonists (DORAs), daridorexant, and lemborexant, and how these DORAs compare to other insomnia treatments with the aim of improving treatment choices, reducing adverse events, and improving patient outcomes.

Duration:00:06:29

Sleep Architecture and Neurotransmitters of Sleep

9/29/2023
Host: Michael E. Yurcheshen, MD, FAASM Insomnia is characterized by difficulty falling asleep, staying asleep, and experiencing non-restorative or poor-quality sleep; it often leaves individuals feeling unrefreshed upon awakening. Symptoms during the day may include fatigue, irritability, impaired focus, and excessive sleepiness. The condition can significantly deteriorate a person’s quality of life, leading to reduced productivity, impaired cognitive function, mood disturbances, and an increased risk of accidents or injuries due to daytime sleepiness. This educational program delves into the pathophysiology and diagnosis of insomnia as well as the role of the orexin system in the sleep/wake cycle. The program also evaluates the latest treatments, including the dual orexin receptor antagonists (DORAs), daridorexant, and lemborexant, and how these DORAs compare to other insomnia treatments with the aim of improving treatment choices, reducing adverse events, and improving patient outcomes.

Duration:00:05:30

Experts Debate: How Novel Excessive Daytime Sleepiness Treatments Fit Into Clinical Practice for Obstructive Sleep Apnea

8/25/2023
Host: Atul Malhotra, MD Host: Neomi Shah, MD, MPH, MSc This curriculum focuses on the recognition and management of excessive daytime sleepiness (EDS) in patients with treated obstructive sleep apnea (OSA). Evidence-based treatment strategies for OSA will be reviewed, including best practices for the use of novel pharmacotherapeutics in the management of persistent EDS caused by OSA.

Duration:00:06:29

Roundtable: Safety and Efficacy Data on New Therapies for Excessive Daytime Sleepiness in Obstructive Sleep Apnea

8/25/2023
Host: Atul Malhotra, MD Host: Neomi Shah, MD, MPH, MSc This curriculum focuses on the recognition and management of excessive daytime sleepiness (EDS) in patients with treated obstructive sleep apnea (OSA). Evidence-based treatment strategies for OSA will be reviewed, including best practices for the use of novel pharmacotherapeutics in the management of persistent EDS caused by OSA.

Duration:00:05:59

Roundtable: Experts Recommend Tools to Diagnose and Monitor Excessive Daytime Sleepiness in Obstructive Sleep Apnea

8/25/2023
Host: Atul Malhotra, MD Host: Christina Finch, MD This curriculum focuses on the recognition and management of excessive daytime sleepiness (EDS) in patients with treated obstructive sleep apnea (OSA). Evidence-based treatment strategies for OSA will be reviewed, including best practices for the use of novel pharmacotherapeutics in the management of persistent EDS caused by OSA.

Duration:00:06:29

The Epidemiology of Sleepiness in Obstructive Sleep Apnea

8/25/2023
Host: Atul Malhotra, MD This curriculum focuses on the recognition and management of excessive daytime sleepiness (EDS) in patients with treated obstructive sleep apnea (OSA). Evidence-based treatment strategies for OSA will be reviewed, including best practices for the use of novel pharmacotherapeutics in the management of persistent EDS caused by OSA.

Duration:00:04:59

Algorithm for Assessing Excessive Daytime Sleepiness in Obstructive Sleep Apnea

8/25/2023
Host: Neomi Shah, MD, MPH, MSc This curriculum focuses on the recognition and management of excessive daytime sleepiness (EDS) in patients with treated obstructive sleep apnea (OSA). Evidence-based treatment strategies for OSA will be reviewed, including best practices for the use of novel pharmacotherapeutics in the management of persistent EDS caused by OSA.

Duration:00:05:59

New Treatments for Residual Excessive Daytime Sleepiness in Obstructive Sleep Apnea

8/25/2023
Host: Christina Finch, MD This curriculum focuses on the recognition and management of excessive daytime sleepiness (EDS) in patients with treated obstructive sleep apnea (OSA). Evidence-based treatment strategies for OSA will be reviewed, including best practices for the use of novel pharmacotherapeutics in the management of persistent EDS caused by OSA.

Duration:00:05:29

Negative Impacts of Excessive Daytime Sleepiness Due to Obstructive Sleep Apnea

8/25/2023
Host: Neomi Shah, MD, MPH, MSc This curriculum focuses on the recognition and management of excessive daytime sleepiness (EDS) in patients with treated obstructive sleep apnea (OSA). Evidence-based treatment strategies for OSA will be reviewed, including best practices for the use of novel pharmacotherapeutics in the management of persistent EDS caused by OSA.

Duration:00:05:30

Case Study: Adjusting STOP-BANG Screening Criteria for Minority Ethnic Groups

8/25/2023
Host: Christina Finch, MD This curriculum focuses on the recognition and management of excessive daytime sleepiness (EDS) in patients with treated obstructive sleep apnea (OSA). Evidence-based treatment strategies for OSA will be reviewed, including best practices for the use of novel pharmacotherapeutics in the management of persistent EDS caused by OSA.

Duration:00:04:59

How to Identify Residual Excessive Daytime Sleepiness in Obstructive Sleep Apnea

8/25/2023
Host: Christina Finch, MD This curriculum focuses on the recognition and management of excessive daytime sleepiness (EDS) in patients with treated obstructive sleep apnea (OSA). Evidence-based treatment strategies for OSA will be reviewed, including best practices for the use of novel pharmacotherapeutics in the management of persistent EDS caused by OSA.

Duration:00:04:59

Targeting the Fc Receptor Pathway to Treat Red Blood Cell Alloimmunization

10/27/2022
Host: Lee P. Shulman, MD, FACMG, FACOG Guest: Kenneth J. Moise Jr., MD This program is no longer available for credit. Program Chairman: Roberto Romero, MD, DMedSci Chief, Perinatology Research Branch Division of Maternal-Fetal Medicine and Obstetrics Division of Intramural Research NICHD/NIH/DHHS Editor-in-Chief for Obstetrics The American Journal of Obstetrics and Gynecology How well do you understand the biology of hemolytic disease of the fetus and newborn (HDFN)? What about its connection to the FcRn receptor pathway and IgG? Drs. Lee Shulman and Ken Moise go beyond the basics taught in medical school immunology and look more closely at FcRn’s role in protecting IgG. With an improved understanding of these mechanisms, we can expand therapeutic targets beyond the fetus and newborn and finally put the needles away.

Duration:00:12:53

The New POSEIDON Criteria: The WHY, the WHAT, and the HOW

1/12/2018
Guest: Sandro Esteves, MD, PhD Recent studies have highlighted limitations of the existing definitions of poor ovarian response. In this video, Dr. Sandro Esteves will review these limitations, explain the new POSEIDON criteria, discuss its new marker of success in Assisted Reproductive Technology, and provide innovative alternatives for clinical management.

Duration:00:14:29

Fertility Preservation Options for Women

11/25/2013
Host: Prathima Setty, MD Fertility preservation technologies have become more advanced and more accessible over the past several years. Joining host Dr. Prathima Setty to discuss current options for women to protect their fertility is Dr. Naveed Khan, Reproductive Endocrinology and Infertility Specialist in Leesburg, VA. Dr. Khan practices with Shady Grove Fertility, the nation's largest fertility center, and is also a member of the American College of Obstetrics and Gynecology and the American Society of Reproductive Medicine.

Duration:00:14:59